Home » MedImmune Speeding Up Drug Applications
MedImmune Speeding Up Drug Applications
Gaithersburg biotechnology company MedImmune, which was acquired by drugmaker AstraZeneca earlier this year, said it expects to have at least three new drug candidates in trials by 2010 and hopes to have an average of six new drug applications for submission per year.
baltimoresun.com
baltimoresun.com
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May